Qiagen NV | QIA - Ebit


Qiagen NV reported $141.4M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.01M 175K Mar/2026
argenx SE USD 493M 99M Jun/2026
Avita Medical AUD -10.39M 1.72M Dec/2025
Dianthus Therapeutics USD -46.53M 23.01M Mar/2026
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
IQVIA Holdings USD 2.6B 2.03B Jun/2026
Moderna USD -815M 573M Jun/2026
Organon & Co USD 291M 33M Jun/2026
Qiagen NV USD 141.4M 44.52M Jun/2026
Revvity USD 126.14M 43.36M Jun/2026
Tectonic Therapeutic USD -27.3M 5.78M Mar/2026
Viatris USD 73.7M 93.9M Jun/2026
Xeris Pharmaceuticals USD 9.12M 7.65M Mar/2026